Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News

EC competition concerns will not stop $17bn Sigma-Aldrich deal, says Merck

28-May-2015 - Merck KGaA is confident it will close the $17bn acquisition of Sigma-Aldrich in mid-2015 despite competition concerns from the European Commission (EC).

Intertek opens new drug stability testing facility citing demand and bigger med devices

26-May-2015 - Intertek has opened a new stability facility citing demand for bespoke drug and device services like abuse potential assessments and stress testing.

Home-brew morphine: Is opiate production about to get way too easy?

21-May-2015 - Access to yeast strains modified to produce opiates for cheaper, more effective pain meds must be strictly controlled according to researchers who warn that stopping criminals using such API manufacturing routes to make illegal narcotics is vital.

Janssen and Rutgers expand R&D as continuous manufacturing picks up steam

20-May-2015 - Despite pharma being “highly regulated and slow to change,” continuous manufacturing will soon be realised, says Rutgers University which has received an R&D grant from J&J.

Endo buys Par, Lupin enters Brazil... it's been a busy week in generics

19-May-2015 - Endo’s $8bn takeover of Par Pharmaceutical is expected to shake-up the generics sector, while Lupin is expanding its South American network – welcome to In-Pharmatechnologist’s M&A round-up.

Hospira approval puts Pfizer on track to close $17bn deal by year's end

18-May-2015 - Pfizer is set to close its $17bn (€15bn) acquisition by the end of the year after receiving the thumbs up from Hospira shareholders.

Lack of talent will hamper continuous manufacturing adoption, says MIT Prof

13-May-2015 - A lack of scientific talent will hold pharma back from adopting continuous manufacturing despite the imminent opening of regulatory pathways, says an MIT Professor.

Sandoz opens $47m packaging centre to support Polish manufacturing site

11-May-2015 - Novartis subsidiary Sandoz has opened a new packaging facility to support the five billion tablets made at a site in Poland.


Hospira to lay off 100 following closure of Clayton, NC plant

07-May-2015 - Hospira’s closure of its manufacturing facility in Clayton, North Carolina, which it says is a cost rather than a quality issue , will result in the laying off of 100 employees, according to a WARN notice  posted Wednesday.

Three-way collaboration to offer packaging serialisation ahead of EU Directive

06-May-2015 - Schott, Heuft and GEA have teamed up to offer drugmakers a serialisation service for primary packaging to help with EU anti-counterfeiting requirements.

FDA calls on manufacturers to begin switch from batch to continuous production

01-May-2015 - Though making the switch from batch to continuous manufacturing may be difficult, costly and time consuming, pharma manufacturers and CMOs should begin to consider the switch as in the long-run it will end up saving companies time, money and space, FDA’s CDER Director Janet Woodcock told congressmen in a hearing Thursday. 

Amgen expands hiring in Massachusetts as other facilities close more quickly

29-Apr-2015 - Biotech giant Amgen has begun hiring about 100 more research scientists and production engineers as part of an expansion at its office in Cambridge, Massachusetts at the same time as laying off more than 2,000 employees at other sites.

Mylan rejects $40bn bid, questions Teva’s credibility

28-Apr-2015 - Mylan has rejected an unsolicited bid by Teva and upped its offer for Perrigo, as the ongoing saga in the generics space continues.

Foreign particles lead Mylan to recall lots of cancer injectables

27-Apr-2015 - Mylan has recalled eight lots of injectables after foreign particulate matter was observed during the testing of samples.

Agilent unveils Q-TOF system for routine analyses

23-Apr-2015 - Agilent Technologies has launched a quadrupole-time of flight (Q-TOF) mass spectrometry system for applications including food safety and pharmaceuticals.

Tech transfer will drive pharma investment in Africa, says industry group

23-Apr-2015 - Technology transfer is the first step to bringing pharma investments to Africa, says the African Regulatory Network (ARN).

Dispatches from Interphex

Roundup of the day’s top news at Interphex

22-Apr-2015 - The world’s top pharma and biologics manufacturing and processing companies have come together in New York this week to showcase the latest in equipment and services.

US-Cuban embargo nears end as Pfizer and Regeneron make trade trip

21-Apr-2015 - Pfizer and Regeneron are in Cuba this week, scouting the country for business opportunities.

Allergan axing a further 577 at Cali HQ, post-Actavis acquisition

21-Apr-2015 - Almost 600 staff at Allergan’s headquarters in Irvine, California, will be laid off in the Botox maker’s latest round of job cuts.

LB Bohle: Tech Center hopes to drive away hesitancy in continuous processing

20-Apr-2015 - LB Bohle has opened a multi-million euro Technology Center it says can help expedite the shift to continuous processing within the pharma industry.

‘We must not rest on our laurels’

GEA revenue growth for 2015 overshadowed by 1,450 job cuts

20-Apr-2015 - GEA said it expects to achieve a moderate organic growth in revenue and an operating EBITDA of between €580 and €620m in the current fiscal year 2015, but its growth is overshadowed by 1,450 job cuts.

Dispatches from BPI 2015

Breakthrough barriers: Seeking fast track review means betting on data says Roche

16-Apr-2015 - To benefit from breakthrough therapy designation (BTD) pharma companies must be willing “bet on the right data” according to Roche, which says this could be a challenge for smaller firms.

Bayer spends $100m on haemophilia development in Berkeley

16-Apr-2015 - Bayer has announced it will create a $100m (€94m) product testing site in California for its haemophilia A pipeline.


Novo Nordisk pushes into Russia with new insulin manufacturing facility

13-Apr-2015 - Novo Nordisk has opened a new manufacturing facility in Russia for the formulation and filling of insulin as a diabetes treatment. 

Almac to relocate protein business to up capacity and add new services

13-Apr-2015 - Almac will transfer its custom peptide manufacturing business to a site at the Edinburgh Technopole business park in Scotland’s capital in a £3.5m move designed to expand capacity.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...